Previous 10 | Next 10 |
PALO ALTO, California , April 4, 2019 /PRNewswire/ -- At a grand opening ceremony held March 8th , the Varian office in Hertford Office Park, Midrand, Johannesburg, South Africa was officially inaugurated. Prior to the opening of the permanent location, a provisional office was ut...
PALO ALTO, Calif. , April 3, 2019 /PRNewswire/ -- At the American Association for Cancer Research (AACR) Annual Meeting in Atlanta, GA , Varian (NYSE: VAR), in partnership with the University of Maryland School of Medicine's Department of Radiation Oncology and the Maryland Proton...
PALO ALTO, Calif. , April 2, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced a 62-year-old male with thyroid cancer was the first patient in Malaysia to be treated on the Halcyon ™ system at Beacon Hospital in Selangor . Halcyon simplifies and enhances virtually every a...
PALO ALTO, Calif. and SEOUL, South Korea , March 26, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced a 55-year-old male with liver cancer at the Korea University Medical Center Anam Hospital , was the first patient in Korea to receive treatment on the Halcyon ™ sys...
PALO ALTO, Calif. and BEIJING , March 25, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it again received the "Best After-Sales Service Award for Radiotherapy Products" in the 2018 Chinese Medical Devices Industry Data and After-Sales Service Survey. Varian is the on...
Amarin (NASDAQ: AMRN ) initiated with Buy rating and $27 (44% upside) price target at Stifel citing its allure as an acquisition target. Shares down 1% premarket. More news on: Amarin Corporation plc, Varian Medical Systems, Inc., Biogen Inc., Healthcare stocks news, Stocks on ...
PALO ALTO, Calif. , March 21, 2019 /PRNewswire/ -- Building on its market-leading efforts in preclinical research aimed at clinical implementation of Flash therapy, Varian (NYSE: VAR) hosted the first meeting of the FlashForward ™ Consortium in Atlanta, Georgia on Mar...
PALO ALTO, Calif. , March 11, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced its second quarter fiscal year 2019 earnings release date and upcoming investor event. Second Quarter Fiscal Year 2019 Earnings The Company will report results for the second quarter of fiscal year...
PALO ALTO, California and MUMBAI, India , March 11, 2019 /PRNewswire/ -- With an estimated 1.8 million new cancer cases a year in India expected by 2025 1 , Tata Trusts and Varian (NYSE: VAR) announced the signing of a framework agreement intended to increase patient access ...
PALO ALTO, Calif. , Feb. 28, 2019 /PRNewswire/ -- In a ceremony officiated by the Regional Council of Central Denmark Region, Anders Kühnau, and attended by both the Danish Prime Minister Lars Løkke Rasmussen, and the Chairman of the A.P. Møller Foundation, Ane Maers...
News, Short Squeeze, Breakout and More Instantly...
Varian Medical Systems Inc. Company Name:
VAR Stock Symbol:
NYSE Market:
Varian Medical Systems Inc. Website:
Varian Announces First Participant Treated in GENESIS II Clinical Trial of Genicular Artery Embolization for Knee Osteoarthritis PR Newswire PALO ALTO, Calif. , Nov. 17, 2022 /PRNewswire/ -- Varian, a Siemens Healthineers company, announced today that the...
Varian and the Cincinnati Children's/University of Cincinnati Medical Center Proton Therapy Center Announce Promising Results from FAST-01, First-in-Human Clinical Trial of Flash Therapy PR Newswire – Results published in JAMA Oncology and presented at ASTRO dem...